Cutler Group LP Curis Inc Call Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Oct 26, 2021
SELL
$6.94 - $8.85 $172,112 - $219,480
-24,800 Reduced 91.51%
2,300 $0
Q2 2021

Jul 19, 2021
BUY
$7.45 - $16.27 $111,005 - $242,423
14,900 Added 122.13%
27,100 $8,000
Q1 2021

Apr 26, 2021
BUY
$8.78 - $12.8 $81,654 - $119,040
9,300 Added 320.69%
12,200 $10,000
Q4 2020

Jan 21, 2021
BUY
$1.08 - $8.2 $3,132 - $23,779
2,900 New
2,900 $3,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email